Keros Therapeutics, Inc. logo KROS - Keros Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $102.60 DETAILS
HIGH: $107.00
LOW: $96.00
MEDIAN: $105.00
CONSENSUS: $102.60
UPSIDE: 811.19%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 0.4 0.4 14.3 18.2 211.2 3.0 0.4 0.0 0.1 0.1 0.0 0 0 0 0 0 0 20 0 0.1 0 0 0 0 0 2.5 2.5 2.5 2.5
Cost of Revenue 0.4 0 0.4 0.4 0 0.3 0.3 0 0 0 0.6 0 0 0 0 0 0 0.3 0 10.0 0 0 0 0 0 4.1 0 0 0
Gross Profit (0.0) 0.4 13.9 17.8 211.2 2.7 0.1 0.0 0.1 0.1 (0.5) 0 0 0 0 0 0 19.7 0 (9.9) 0 0 0 0 0 (1.6) 0 0 0
Operating Expenses
R&D Expenses 16.1 17.9 19.5 43.5 48.7 45.6 49.2 40.5 38.3 37.5 34.1 32.5 31.1 24.9 21.0 23.3 18.1 18.8 14.8 10.0 11.5 9.7 8.4 7.3 8.5 4.2 3.9 4.5 4.9
SG&A Expenses 10.1 11.7 10.1 14.5 10.5 10.7 9.8 10.0 10.3 9.1 8.6 8.8 7.8 7.1 6.9 7.4 6.0 5.7 5.4 5.7 4.3 3.6 3.6 3.6 2.0 1.1 1.0 0.7 0.5
Other Expenses (0.4) 0 (0.4) (0.4) 0 (0.3) (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 (10.0) 0 0 0 0 0 (0.0) 0 0 0
Operating Expenses 25.8 29.7 29.3 57.6 59.2 56.0 58.7 50.5 48.6 46.6 42.7 41.3 38.9 32.0 28.0 30.7 24.1 24.6 20.2 5.7 15.8 13.3 11.9 10.9 10.5 5.2 4.8 5.2 5.4
Operating Income
Operating Income (25.9) (29.3) (15.4) (39.8) 152.0 (53.3) (58.7) (50.4) (48.5) (46.5) (43.3) (41.3) (38.9) (32.0) (28.0) (30.7) (24.1) (4.9) (20.2) (15.5) (15.8) (13.3) (11.9) (10.9) (10.5) (2.7) (2.3) (2.7) (2.9)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (23.3) (24.6) (8.3) (32.5) 158.8 (29.1) (52.6) (45.0) (42.8) (40.0) (38.9) (37.3) (35.6) (29.6) (23.4) (27.0) (24.1) (4.6) (20.2) (15.4) (15.8) (10.6) (12.0) (10.7) (12.0) (0.4) (3.5) (2.2) (2.6)
EBIT (23.7) (25.0) (8.7) (32.9) 158.5 (29.5) (53.0) (45.3) (43.1) (40.2) (39.4) (37.5) (35.8) (29.7) (23.5) (27.3) (24.2) (4.9) (20.3) (15.6) (15.8) (10.7) (12.0) (10.8) (12.1) (0.4) (3.5) (2.3) (2.7)
Income Before Tax (23.7) (25.0) (8.7) (32.9) 158.5 (45.7) (53.0) (45.3) (43.1) (40.2) (39.4) (37.5) (35.8) (29.7) (23.5) (27.3) (24.2) (4.9) (20.3) (15.6) (15.8) (10.7) (12.0) (10.8) (12.1) (2.8) (3.5) (2.9) (3.2)
Income Tax Expense 0 (1.5) (1.4) (2.2) 10.0 0.3 0 0 0 0 0 0 0 0 0 0 0 2.0 (0.0) 0 0.1 0 0 0 (0.2) 0 0 0 0
Net Income (23.7) (23.5) (7.3) (30.7) 148.5 (46.0) (53.0) (45.3) (43.1) (40.2) (39.4) (37.5) (35.8) (29.7) (23.5) (27.3) (24.2) (6.9) (20.3) (15.6) (15.9) (10.7) (12.0) (10.8) (11.9) (2.8) (3.5) (2.9) (3.2)
Per Share Data
EPS (Basic) -0.64 -0.86 -0.18 -0.76 3.66 -1.14 -1.47 -1.25 -1.46 -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 -0.62 -0.70 -0.31 -0.45 -0.37 -0.41
EPS (Diluted) -0.63 -0.38 -0.18 -0.76 3.62 -1.14 -1.47 -1.25 -1.46 -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 -0.62 -0.70 -0.31 -0.45 -0.37 -0.41
Shares Outstanding 37.2 37.2 40.6 40.6 40.6 40.3 36.1 36.1 29.4 30.1 29.7 29.6 28.4 27.3 25.5 24.1 24.0 23.4 23.4 23.3 23.2 21.6 20.2 17.6 18.2 8.9 8.9 8.9 8.9
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 281.5 287.4 693.5 690.2 720.5 559.9 530.7 405.9 442.4 331.1 287.9 322.0 351.4 279.0 239.4 215.6 228.6 230.0 221.3 237.1 255.2 265.9 133.8 144.7 54.5 7.0 (23.3)
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46.5
Net Receivables 3.0 6.4 5.6 17.7 19.4 4.5 1.9 1.3 1.8 1.1 0.9 1.0 1.1 0.8 0.1 0.1 0.2 18.2 0.2 0.2 0 0.2 0.2 0.2 1.0 0.9 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.0 2.4 2.7 2.5 2.9 1.5 1.4 0.6 0.6 1.0 0.3 0.4 0.5 0.3 0.7 0.5 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.3 0.4 0.8 0
Total Current Assets 290.7 315.4 719.3 732.8 759.5 588.9 552.0 432.7 463.1 347.3 304.4 334.3 362.2 285.8 245.9 222.4 231.2 251.4 226.1 241.4 256.0 267.7 136.4 148.5 56.5 8.9 23.3
Non-Current Assets
Property, Plant & Equipment 20.2 21.1 22.0 22.9 23.1 23.5 24.2 18.9 19.4 19.5 19.0 19.1 19.3 17.6 2.1 2.3 2.3 2.4 2.6 1.9 1.6 1.6 1.7 1.8 1.9 1.9 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 1.4 1.4 0 1.4 1.4 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0
Other Non-Current Assets 1.4 0 0 1.4 0.5 2.1 1.6 3.4 3.3 3.3 2.8 2.9 2.9 3.4 4.5 2.0 1.6 1.4 1.3 0.1 0.1 0.1 0.1 0.1 2.0 0.1 (23.3)
Total Non-Current Assets 21.6 22.6 23.5 24.4 25.1 27.0 27.2 22.3 22.7 22.7 21.8 22.0 22.2 21.0 6.7 4.3 3.9 3.8 3.9 2.0 1.7 1.7 1.8 1.9 4.1 2.0 (23.3)
Total Assets 312.3 338.0 742.8 757.2 784.6 615.9 579.3 455.0 485.8 370.0 326.2 356.3 384.4 306.8 252.6 226.7 235.1 255.3 230.0 243.5 257.7 269.4 138.2 150.4 60.6 11.0 0
Current Liabilities
Account Payables 1.5 2.0 2.3 5.3 6.6 4.6 5.0 6.5 5.0 5.5 3.9 4.1 4.7 3.3 2.7 7.7 3.1 3.6 2.8 1.4 3.0 2.1 1.7 4.9 2.4 2.1 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0
Deferred Revenue 0 0 0.2 0.9 3.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.5 6.1 9.2 8.5 5.8 0.4 8.4 5.8 4.8 8.2 6.5 4.5 3.0 5.6 4.2 3.2 1.4 2.6 2.0 1.8 0.8 1.7 1.6 1.3 5.6 1.0 0
Total Current Liabilities 12.9 20.4 24.1 34.7 39.4 27.4 29.0 21.2 18.7 24.4 16.7 16.1 15.5 16.5 11.5 15.5 11.6 11.8 11.0 7.5 8.9 7.2 6.8 8.3 8.8 4.5 0
Non-Current Liabilities
Long-Term Debt 13.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 75.7 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 5.1 0
Total Non-Current Liabilities 13.8 14.5 15.1 15.7 16.3 16.9 17.4 12.9 13.2 13.4 13.7 14.0 14.0 12.8 0 0 0 0.2 0.5 0.3 0.4 0.5 0.7 0.8 76.6 6.0 0
Total Liabilities 26.7 34.9 39.2 50.4 55.7 44.3 46.4 34.1 31.9 37.8 30.4 30.0 29.5 29.4 11.5 15.5 11.6 12.1 11.5 7.8 9.4 7.7 7.5 9.1 85.5 10.5 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (505.5) (481.8) (458.3) (451.0) (420.3) (568.8) (522.8) (469.8) (424.5) (381.4) (341.2) (301.7) (264.2) (228.4) (198.7) (175.2) (147.9) (123.8) (116.8) (96.5) (80.9) (65.0) (54.3) (42.3) (31.5) (19.6) 0
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (7.2)
Total Stockholders' Equity 285.6 303.1 703.6 706.7 728.9 571.6 532.8 420.9 453.9 332.2 295.8 326.3 355.0 277.4 241.0 211.2 223.5 243.2 218.5 235.7 248.4 261.7 130.8 141.4 (24.9) 0.5 12.8
Total Liabilities & Equity 312.3 338.0 742.8 757.2 784.6 615.9 579.3 455.0 485.8 370.0 326.2 356.3 384.4 306.8 252.6 226.7 235.1 255.3 230.0 243.5 257.7 269.4 138.2 150.4 60.6 11.0 12.8
Debt Metrics
Total Debt 16.3 16.9 17.4 18.0 18.4 18.9 19.3 14.0 14.2 14.4 14.3 14.0 14.0 13.3 0.5 0.7 0.9 1.1 1.3 0.7 0.8 0.9 1.0 1.1 76.9 1.3 0
Net Debt (265.2) (270.5) (676.0) (672.3) (702.1) (541.1) (511.4) (391.9) (428.2) (316.7) (273.6) (308.1) (337.4) (265.8) (239.0) (215.0) (227.7) (228.9) (220.1) (236.4) (254.4) (265.0) (132.8) (143.6) 22.4 (5.7) 23.3
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (23.7) (23.5) (7.3) (30.7) 148.5 (46.0) (53.0) (45.3) (43.1) (40.2) (39.4) (37.5) (35.8) (29.7) (23.5) (27.3) (24.2) (6.9) (20.3) (15.6) (15.9) (10.7) (12.0) (10.8) (11.9) (2.8) (3.5) (2.9) (3.2)
Depreciation & Amortization 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Stock-Based Compensation 6.2 7.3 4.0 8.5 8.9 9.2 8.8 8.8 8.1 7.3 8.7 7.0 5.7 4.7 4.8 4.8 4.4 3.3 3.1 2.8 2.5 1.5 1.4 1.1 0.0 0.0 0.0 0.0 0.0
Change in Working Capital 12.9 (12.2) 5.5 (8.4) 2.9 (10.1) 12.8 (4.0) (10.1) 6.9 (3.8) (0.9) (4.8) 3.1 (6.2) (0.6) 18.1 (17.0) 3.3 (5.1) 2.7 1.0 (0.4) (0.5) 2.1 (3.7) (0.1) (2.9) (0.0)
Other Non-Cash Items 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.3 0.3 0.3 0.3 0.4 0.5 0.3 0.2 0.2 0.2 0.9 (0.6) 0.1 0.1 0.1 0.0 0.1 1.6 0.9 0.6 0.7 0.7
Operating Cash Flow (3.5) (27.3) 3.2 (29.6) 161.2 (46.0) (30.5) (39.8) (44.6) (25.5) (34.0) (30.8) (34.2) (21.4) (24.6) (22.6) (1.4) (19.6) (14.4) (17.6) (10.5) (8.0) (10.9) (9.9) (8.1) (5.5) (3.0) (5.0) (2.5)
Investing Activities
Capital Expenditure (0.1) (0.1) (0.1) (0.7) (0.6) (0.3) (0.4) (0.3) (0.9) (0.5) (0.6) (0.3) (1.1) (0.4) (0.2) (0.6) (0.1) (0.2) (0.1) (0.5) (0.2) (0.1) (0.0) (0.0) (0.2) (0.0) (0.1) (0.2) 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (0.1) (0.1) (0.1) (0.7) (0.6) (0.3) (0.4) (0.3) (0.9) (0.5) (0.6) (0.3) (1.1) (0.4) (0.2) (0.6) (0.1) (0.2) (0.1) (0.5) (0.2) (0.1) (0.0) (0.0) (0.2) (0.0) (0.1) (0.2) 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (2.3) (378.8) 0.0 0 0 2.4 0.9 2.9 5.5 0.7 0 0 0.4 0.0 0.1 0.5 0 0.2 0 0 0 (0.4) 0.0 100.1 (0.2) 0.0 0.0 0.0 0
Financing Cash Flow (2.3) (378.6) 0.1 0.0 0.0 75.5 155.9 3.5 156.8 69.3 0.3 1.7 107.7 61.4 48.6 10.2 0.1 28.4 0.0 0.1 0.0 140.1 0.0 100.1 55.8 0.0 0.0 0.0 0
Cash Position
Net Change in Cash (5.9) (406.1) 3.3 (30.3) 160.6 29.2 125.1 (36.6) 111.3 43.3 (34.1) (29.4) 72.4 39.6 23.8 (13.0) (1.5) 8.7 (15.8) (18.1) (10.7) 132.1 (10.9) 90.2 47.5 (5.5) (3.0) (5.2) (2.5)
Cash at Beginning 287.4 694.9 691.7 722.0 561.4 532.1 407.1 443.7 332.4 289.1 322.0 351.4 280.4 240.8 216.9 229.9 230.0 222.7 237.1 255.2 265.9 133.9 144.8 54.6 7.1 12.6 15.7 20.9 23.4
Cash at End 281.5 288.9 694.9 691.7 722.0 561.4 532.1 407.1 443.7 332.4 287.9 322.0 352.8 280.4 240.8 216.9 228.6 231.4 221.3 237.1 255.2 266.0 133.9 144.8 54.6 7.1 12.6 15.7 20.9
Free Cash Flow (3.6) (27.4) 3.1 (30.3) 160.6 (46.3) (30.9) (40.1) (45.5) (26) (34.5) (31.1) (35.3) (21.8) (24.8) (23.2) (1.6) (19.7) (14.6) (18.1) (10.7) (8.1) (10.9) (10.0) (8.3) (5.5) (3.0) (5.2) (2.5)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 0.4 0.4 14.3 18.2 211.2 3.0 0.4 0.0 0.1 0.1 0.0 0 0 0 0 0 0 20 0 0.1 0 0 0 0 0 2.5 2.5 2.5 2.5
Gross Profit (0.0) 0.4 13.9 17.8 211.2 2.7 0.1 0.0 0.1 0.1 (0.5) 0 0 0 0 0 0 19.7 0 (9.9) 0 0 0 0 0 (1.6) 0 0 0
Operating Income (25.9) (29.3) (15.4) (39.8) 152.0 (53.3) (58.7) (50.4) (48.5) (46.5) (43.3) (41.3) (38.9) (32.0) (28.0) (30.7) (24.1) (4.9) (20.2) (15.5) (15.8) (13.3) (11.9) (10.9) (10.5) (2.7) (2.3) (2.7) (2.9)
Net Income (23.7) (23.5) (7.3) (30.7) 148.5 (46.0) (53.0) (45.3) (43.1) (40.2) (39.4) (37.5) (35.8) (29.7) (23.5) (27.3) (24.2) (6.9) (20.3) (15.6) (15.9) (10.7) (12.0) (10.8) (11.9) (2.8) (3.5) (2.9) (3.2)
EPS (Diluted) -0.63 -0.38 -0.18 -0.76 3.62 -1.14 -1.47 -1.25 -1.46 -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 -0.62 -0.70 -0.31 -0.45 -0.37 -0.41
Balance Sheet
Cash & Equivalents 281.5 287.4 693.5 690.2 720.5 559.9 530.7 405.9 442.4 331.1 287.9 322.0 351.4 279.0 239.4 215.6 228.6 230.0 221.3 237.1 255.2 265.9 133.8 144.7 54.5 7.0 (23.3)
Total Assets 312.3 338.0 742.8 757.2 784.6 615.9 579.3 455.0 485.8 370.0 326.2 356.3 384.4 306.8 252.6 226.7 235.1 255.3 230.0 243.5 257.7 269.4 138.2 150.4 60.6 11.0 0
Total Debt 16.3 16.9 17.4 18.0 18.4 18.9 19.3 14.0 14.2 14.4 14.3 14.0 14.0 13.3 0.5 0.7 0.9 1.1 1.3 0.7 0.8 0.9 1.0 1.1 76.9 1.3 0
Stockholders' Equity 285.6 303.1 703.6 706.7 728.9 571.6 532.8 420.9 453.9 332.2 295.8 326.3 355.0 277.4 241.0 211.2 223.5 243.2 218.5 235.7 248.4 261.7 130.8 141.4 (24.9) 0.5 12.8
Cash Flow
Operating Cash Flow (3.5) (27.3) 3.2 (29.6) 161.2 (46.0) (30.5) (39.8) (44.6) (25.5) (34.0) (30.8) (34.2) (21.4) (24.6) (22.6) (1.4) (19.6) (14.4) (17.6) (10.5) (8.0) (10.9) (9.9) (8.1) (5.5) (3.0) (5.0) (2.5)
Capital Expenditure (0.1) (0.1) (0.1) (0.7) (0.6) (0.3) (0.4) (0.3) (0.9) (0.5) (0.6) (0.3) (1.1) (0.4) (0.2) (0.6) (0.1) (0.2) (0.1) (0.5) (0.2) (0.1) (0.0) (0.0) (0.2) (0.0) (0.1) (0.2) 0
Free Cash Flow (3.6) (27.4) 3.1 (30.3) 160.6 (46.3) (30.9) (40.1) (45.5) (26) (34.5) (31.1) (35.3) (21.8) (24.8) (23.2) (1.6) (19.7) (14.6) (18.1) (10.7) (8.1) (10.9) (10.0) (8.3) (5.5) (3.0) (5.2) (2.5)